Loading…
2 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Oktopusi | Fitness & Wellness | 48.6% | 97th pct | 30 |
| Oda | Industrial Goods | -28.9% | 4th pct | 534 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2024 | Oktopusi | Oda |
|---|---|---|
| Margins | ||
| Gross Margin | 100.0% | 77.4% |
| EBITDA Margin | 48.6% | -28.9% |
| EBITDAR | 9,218 | -288 |
| EBITDAR Margin | 63.0% | -28.9% |
| EBIT Margin | 42.1% | -47.4% |
| Net Profit Margin | 6.0% | -50.4% |
| Operating Expense % of Sales | 51.4% | 106.3% |
| Returns | ||
| Return on Assets (ROA) | 9.0% | -5.2% |
| Return on Equity (ROE) | 37.8% | -5.2% |
| ROIC [EBIT / Invested Capital] | 84.1% | -5.2% |
| Leverage & debt balances | ||
| Debt-to-Assets | 54.3% | 0.0% |
| Debt-to-Equity | 2.29x | 0.00x |
| Debt-to-EBITDA | 0.75x | N/A |
| Equity-to-Assets | 23.7% | 99.5% |
| Net Debt | 4,990 | -496 |
| Cash & Equivalents | 348 | 496 |
| Total Debt | 5,339 | N/A |
| Liquidity & working capital | ||
| Current Ratio | 1.80x | 12.47x |
| Quick Ratio | 1.80x | 12.47x |
| Cash Ratio | 0.43x | 12.47x |
| Total Current Assets | 1,469 | 496 |
| Total Current Liabilities | 816 | 40 |
| Inventory | N/A | N/A |
| Trade Receivables | 67 | 3,028 |
| Trade Payables | 682 | 40 |
| Net Working Capital | 653 | 456 |
| Net Working Capital % of Revenue | 4.5% | 45.8% |
| Trade Working Capital | -615 | 2,988 |
| Trade Working Capital % of Revenue | -4.2% | 299.8% |
| Change in Trade Working Capital | N/A | N/A |
| Turnover & efficiency | ||
| Inventory Turnover | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A |
| Receivables Turnover | 218.91x | 0.33x |
| Days Sales Outstanding (DSO) | 1.7 | 1109.0 |
| Payables Turnover | N/A | 5.67x |
| Days Payable Outstanding (DPO) | N/A | 64.3 |
| Cash Conversion Cycle | 1.7 days | 1044.7 days |
| Asset Turnover | 1.49x | 0.10x |
| Cash flow & dividends | ||
| Operating Cash Flow | -62 | N/A |
| Free Cash Flow (OCF − Capex proxy) | -62 | N/A |
| Cash Conversion (OCF / EBITDA) | -0.9% | N/A |
| Dividends Declared | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A |